Role of incretin, incretin analogues and dipeptidyl peptidase 4 inhibitors<br /> in the pathogenesis and treatment of diabetes mellitus
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 5
Abstract
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived incretin hormones that stimulate insulin and suppress glucagon secretion, inhibit gastric emptying, and reduce appetite and food intake. An additional action of GLP-1 is the in vitro inhibition of β-cell apoptosis. GLP-1 can significantly lower plasma glucose in the majority of patients with type 2 diabetes. GLP-1 is inactivated rapidly in vivo by dipeptidyl peptidase 4 (DPP-4) and thus does not appear to be useful as a therapeutic agent in the long-term treatment of diabetes. Therapeutic approaches for enhancing incretin action include degradation-resistant GLP-1 receptor agonists, and inhibitors of DPP-4 activity. Clinical trials with the incretin mimetic exenatide and liraglutide show reduction in fasting and postprandial glucose concentration, and HbA1c, associated with weight loss, but also some nausea and, rarely, vomiting. The DPP-4 inhibitors (vildagliptin, sitagliptin, saxagliptin) control elevated blood glucose by promoting pancreatic insulin secretion, suppressing pancreatic glucagon secretion, and reducing glucose production by the liver. The DPP-4 inhibitors have shown clinically significant HbA1c reduction with a low risk of hypoglycemia and no effect on body weight, and the potential, based on animal and in vitro studies, for the regeneration and differentiation of pancreatic β-cells. However, long-term clinical studies are needed to determine the benefits of targeting the incretin axis for the treatment of type 2 diabetes.
Authors and Affiliations
S. PAPAS, A. PAPAZAFIROPOULOU
Keywords
Related Articles
- EP ID EP144557
- DOI -
- Views 118
- Downloads 0
Γενετική και μοριακή βάση της νόσου του Parkinson
Η νόσος του Parkinson είναι μια συχνή προοδευτική εκφυλιστική νόσος του κεντρικού νευρικού συστήματος, η οποία προσβάλλει περίπου το 1% των ενηλίκων ηλικίας >60 ετών. Χαρακτηρίζεται από μυϊκή δυσκαμψία, τρόμο ηρεμίας, βρ...
Η νόσος Gaucher στην Ελλάδα<br /> Εργαστηριακή διερεύνηση
ΣΚΟΠΟΣ Η βιοχημική και μοριακή διερεύνηση της νόσου Gaucher στην Ελλάδα. ΥΛΙΚΟ-ΜΕΘΟΔΟΣ Μελετήθηκαν κλινικά ύποπτοι ασθενείς από όλη την Ελλάδα. Ο βιοχημικός έλεγχος περιελάμβανε τη μέτρηση της χιτοτριοζιδάσης στο πλά...
Catalog of uniform nomenclature and coding of laboratory tests
In March 2013, the Health Procurement Committee of the Greek Ministry of Health appointed a committee consisting of laboratory scientists to compile a list of laboratory tests performed on biological fluids, cells and ti...
Comparison of the mental and physical health and quality of life of Greeks, Albanian immigrants and returnees from the former Soviet Union
OBJECTIVE Investigation of the perceptions of Greeks, immigrants from Albania and returnees from the former Soviet Union about their quality of life, and its relationship with their general physical and mental health. Re...
Στοιχεία της φροϋδικής θεωρίας στο Βυζάντιο
Τη βυζαντινή περίοδο, τα πρώιμα δείγματα της ψυχολογίας του βάθους, που εισάγονται από τον Πλάτωνα, εξελίσσονται και διαμορφώνονται συστηματικά. Αναγνωρίζεται το υποσυνείδητο και η σημασία της τραυματικής εμπειρίας. Στο...